Will US Doctors Prescribe Biosimilars?
An InCrowd Syndicated Report on biosimilars adoption in the US.
You’ll learn about physician and pharmacist attitudes, perceptions, and expectations around the onset of biosimilars in the US. Get the key takeaways from a 6-minute microsurvey of this group of healthcare stakeholders.
